LAKESIDE HOLDING LAUNCHES NEW PICK & PACK FULFILLMENT SERVICE ACROSS KEY U.S. HUBS FOR LONGSTANDING CHINA LOGISTICS PARTNERby September 3, 2024PR Newswire
TrinaTracker demonstrates upgraded Vanguard 1P solution at Intersolar South Americaby September 3, 2024PR Newswire
Radisson Hotel Group delivers strong growth with over 130 new signings and openings internationally during HY1 2024by September 3, 2024PR Newswire
Insilico will unveil its innovative ‘Fire Extinguishing Capsule’ at APCS 2024 this Septemberby September 3, 2024PR Newswire
Canadian Solar and SOLARCYCLE Ink Landmark Cradle-to-Cradle U.S. Recycling Partnershipby September 3, 2024PR Newswire
DataFeedWatch by Cart.com Becomes the First Feed Management Solution to Introduce Native AIby September 3, 2024PR Newswire
Skyline Therapeutics’ Novel Gene Therapy SKG1108 Receives FDA Orphan Drug Designation for Retinitis Pigmentosaby September 3, 2024PR Newswire
Tuniu Announces Strategic Cooperation with the Tourism Authority of Thailandby September 3, 2024PR Newswire
Iridium Unveils Iridium Certus GMDSS: Defining a New Standard in Maritime Safety and Communicationsby September 3, 2024PR Newswire
JinkoSolar Completes Delivery of PV Modules Donated to Aid Maui Fire Victimsby September 3, 2024PR Newswire
NGSC24: Esports World Cup Foundation Signs MoU with China Media Group and VSPOby September 3, 2024PR Newswire
Enfinity Global secures € 190 million financing for a 157 MW solar power portfolio in Italyby September 3, 2024PR Newswire
GeneOnline: Core8 Australia, Truongson Land, and Him Lam Form VIEH Singapore to Drive Investment in Vietnam’s Duc Hoa 3 Industrial Parkby September 3, 2024PR Newswire
IFS assyst named a Leader and Fast Mover in the GigaOm Radar for IT Service Management (ITSM)by September 3, 2024PR Newswire
Keding Enterprises Announces Global Partnership Opportunities in Innovative Building Materialsby September 3, 2024PR Newswire
Keding Enterprises ประกาศโอกาสในการร่วมเป็นพันธมิตรระดับโลกด้านวัสดุก่อสร้างนวัตกรรมใหม่by September 3, 2024PR Newswire
GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDAby September 3, 2024PR Newswire
